» Articles » PMID: 36798435

Distinct Dosage Compensations of Ploidy-sensitive and -insensitive X Chromosome Genes During Development and in Diseases

Overview
Journal iScience
Publisher Cell Press
Date 2023 Feb 17
PMID 36798435
Authors
Affiliations
Soon will be listed here.
Abstract

The active X chromosome in mammals is upregulated to balance its dosage to autosomes during evolution. However, it is elusive why the known dosage compensation machinery showed uneven and small influence on X genes. Here, based on >20,000 transcriptomes, we identified two X gene groups (ploidy-sensitive [PSX] and ploidy-insensitive [PIX]), showing distinct but evolutionarily conserved dosage compensations (termed XAR). We demonstrated that XAR-PIX was downregulated whereas XAR-PSX upregulated at both RNA and protein levels across cancer types, in contrast with their trends during stem cell differentiation. XAR-PIX, but not XAR-PSX, was lower and correlated with autoantibodies and inflammation in patients of lupus, suggesting that insufficient dosage of PIX genes contribute to lupus pathogenesis. We further identified and experimentally validated two XAR regulators, and . Collectively, we provided insights into X dosage compensation in mammals and demonstrated different regulation of PSX and PIX and their pathophysiological roles in human diseases.

Citing Articles

Sex Disparities in P53 Regulation and Functions: Novel Insights for Personalized Cancer Therapies.

Cardano M, Buscemi G, Zannini L Cells. 2025; 14(5).

PMID: 40072091 PMC: 11898824. DOI: 10.3390/cells14050363.


Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the and Genes.

Ndou L, Chambuso R, Algar U, Boutall A, Goldberg P, Ramesar R Biomedicines. 2025; 12(12.

PMID: 39767815 PMC: 11672899. DOI: 10.3390/biomedicines12122906.


Sex-biased genome-editing effects of CRISPR-Cas9 across cancer cells dependent on p53 status.

Guo M, Xiong Y iScience. 2023; 26(9):107529.

PMID: 37636042 PMC: 10448110. DOI: 10.1016/j.isci.2023.107529.

References
1.
Sirchia S, Ramoscelli L, Grati F, Barbera F, Coradini D, Rossella F . Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. Cancer Res. 2005; 65(6):2139-46. DOI: 10.1158/0008-5472.CAN-04-3465. View

2.
Gewandter J, Bambara R, OReilly M . The RNA surveillance protein SMG1 activates p53 in response to DNA double-strand breaks but not exogenously oxidized mRNA. Cell Cycle. 2011; 10(15):2561-7. PMC: 3180194. DOI: 10.4161/cc.10.15.16347. View

3.
Li B, Qing T, Zhu J, Wen Z, Yu Y, Fukumura R . A Comprehensive Mouse Transcriptomic BodyMap across 17 Tissues by RNA-seq. Sci Rep. 2017; 7(1):4200. PMC: 5482823. DOI: 10.1038/s41598-017-04520-z. View

4.
Peng X, Thierry-Mieg J, Thierry-Mieg D, Nishida A, Pipes L, Bozinoski M . Tissue-specific transcriptome sequencing analysis expands the non-human primate reference transcriptome resource (NHPRTR). Nucleic Acids Res. 2014; 43(Database issue):D737-42. PMC: 4383927. DOI: 10.1093/nar/gku1110. View

5.
Friedrich D, Friedel L, Finzel A, Herrmann A, Preibisch S, Loewer A . Stochastic transcription in the p53-mediated response to DNA damage is modulated by burst frequency. Mol Syst Biol. 2019; 15(12):e9068. PMC: 6886302. DOI: 10.15252/msb.20199068. View